Remedy: Lowered budget assumptions on key projects - Redeye

Redeye keeps its valuation range and base case unchanged despite a lowered revenue and EBIT expectation in 2023. Since decreased budget assumptions only have an impact on Remedy’s short-term revenue, we are still optimistic regarding its more long-term prospects, due to the fact that a lower budget in our view increases the royalty opportunity.

Länk till analysen i sin helhet: https://www.redeye.se/research/865562/remedy-lowered-budget-assumptions-on-key-projects?utm_source=finwire&utm_medium=RSS